1.1 General Population
Prevalences within the author's selected populations are
listed. Those that are assigned randomly selected ("unselected") with numbers
more than 500 may be regarded as representative of the "general population".
Inclusion criteria may involve circumstances not related to atopic predisposition
according to current knowledge.
Country / Subjects | Allergy / Sensitivity to | References |
Sweden (Göteborg,
Uppsala, Västerbotten)
1397 unselected adults, age of 20-44 years (study period 1991-92) |
soybean 2% (RAST) | Björnsson et al. 1996 |
1.2 Subjects with Atopic or Other Diseases
Country / Subjects | Allergy / Sensitivity to | References |
Australia, Victoria
100 cow's milk allergic children |
soy milk 47% (parents reported) | Bishop et al. 1990 |
Crotia, Zagreb
35 animal feed workers |
soybean 29% (SPT) | Zuskin et al. 1992 |
Finland, Oulu
children with atopic dermatits |
soybean 2.8%, 5.0%, and 13% in patients < 1 year, 1-3 years, and 3-15 years of age (n=36, 40, 40) (SPT) | Hannuksela 1987 |
France
80 cases of food- related anaphylaxis (from 1993-97) |
soy flour 2.5% (reported to CICBAA databank) | European Commission 1998 |
France, Meuse
742 agricultural workers |
soybean dust 6.5% (SPT) | Maria et al. 1991 |
France, Pierre Benite
a) 580 patients with adverse reactions to food b) 60 cases of anaphylaxis (study period 1984-92) |
a) soybean 30% (RAST)
b) soybean 3.3% |
Andre et al. 1994 |
France, Nancy and Toulouse
544 food allergic children |
soybean 1.2% (food challenge) | Rance et al. 1999 |
Germany,Berlin
107 children with atopic dermatitis |
soybean 16% (n=45, DBPCFC) | Niggemann et al. 1999 |
Germany,Bonn
250 patients with suspected food allergy |
soybean 10% (clinical history, oral challenge) | Mistereck et al. 1992 |
Germany,Bonn
150 children allergic to egg white, milk, cod fish, wheat, peanut and/or soybean |
soybean 46% (RAST) | Liappis & Starke 1999 |
Germany, Ulm
24 legume-sensitive adults |
soybean 21% (SPT, RAST) | Hagner et al. 1998 |
Italy, Milano
71 children with food intolerance |
soybean 17% (oral challenge) | Bardare et al. 1988 |
Italy, Milano
704 atopic children |
soybean 21% (SPT),
from which 6% were DBPCFC-positive |
Magnolfi et al. 1996 |
Italy, Rome
371 children with food allergy |
soy 22% (RAST)
soy 3% (positive challenge) |
Giampietro et al. 1992 |
Italy, Rome
174 infants at risk for atopy |
soybean 5% (RAST) | Bruno et al. 1995 |
Italy, Rome
a) 505 children with food allergy b) 243 children at risk for atopy |
a) soybean 6% (SPT) from which 19% had positive challenge
b) soybean 6% (SPT) from which 1/14 were DBPCFC-positive |
Bruno et al. 1997 |
Japan, Gifu, Nabu
children with asthma and/or atopic dermatitis from Gifu (n = 167) and Nanbu (n = 146) |
soybean 6.8% (Nanbu), 18% (Gifu) (RAST) | Agata et al. 1994 |
Japan, Tokyo
39 children with positive food challenge |
soybean 10% (positive challenge) | Iwasaki et al. 1994 |
Japan, Tokushima
86 patients with atopic dermatitis |
soybean 20% (SDS-PAGE immunoblot) | Ogawa et al. 1991 |
Netherlands
131 cases of food- induced anaphylaxis (from 1993-1997) |
legumes (excluding peanut) 4.6% (survey, reported to the TNO Nutrition and Food Research Institute) | European Commission 1998 |
Netherlands, Rotterdam
91 patients with atopic dermatitis |
soybean 1% (SAFT) | Oranje et al. 1992 |
Poland
163 food allergic infants |
soybean 52% (RAST) | Hofman 1994 |
Spain, Cartagena
patients with asthma (associated to asthma outbreak during the unloading of soybeans) |
soybean 81% (SPT) | Navarro et al. 1993 |
Spain, Tarragona
15 atopic patients affected by a soybean asthma outbreak |
soybean 87% (SPT) | Garcia-Ortega et al. 1998 |
South Africa, Cape Town
112 children with atopic dermatitis (age of 5 months to 13 years) |
soybean 3.6% (questionaire) | Steinman & Potter 1994 |
South Afrika, Johannesburg
22 workers exposed to soybean dust |
soybean 36% (SPT)
soybean 36% (RAST) |
Roodt & Rees 1995 |
Sweden
61 cases of food- induced anaphylaxis (from 1994-1996) |
legumes (excluding peanut) 23% (reported to the National Food Administration) | European Commission 1998 |
Sweden
55 cases of food- induced anaphylaxis (from 1994-1996) |
legumes (excluding peanut) 27% (Hospital Reports) | European Commission 1998 |
Sweden, Linköping
76 healthy newborn babies (at 8 months) |
soybean 6% (RAST)
(0% at 3, 25, and 48 months) |
Hattevig et al. 1984 |
Sweden, Malmö
20 cow's milk allergic infants |
soybean in 35% (clinical history) | Jakobsson & Lindberg 1979 |
Sweden
60 severe allergic reactions caused by food |
soybean, nuts and almonds >70% | Foucard et al. 1997 |
Switzerland, Zurich
402 food allergic adults (study period 1978-87) |
soybean 1% (clinical history, diagnostic tests) | Wüthrich 1993 |
Switzerland, Zurich
383 food allergic patients (study period 1990-94) |
soybean 9% (clinical history, diagnostic tests) | Etesamifar & Wüthrich 1998 |
Thailand, Bangkok
cow's milk-sensitive children |
soybean 17% (clinical history) | Harikul et al. 1995 |
Thailand
100 asthmatic children |
soy 4% (SPT) | Kongpanichkul et al. 1997 |
UK
a) 394 bread bakery and b) 77 cake bakery workers |
soy a) 7%, b) 1% (SPT) | Smith & Smith 1998 |
UK, London
100 patients with food intolerance |
soy 1% (repeated challenge) | Lessof et al. 1980 |
UK, Manchester
172 patients expierenced anaphylactic reactions to foods (from 1994-1996) |
legumes (excluding peanut) 2.3% (suspected cause of patients' worst reaction) | Pumphrey & Stanworth 1996 |
USA, Baltimore, MD
196 food-allergic patients with atopic dermatitis |
soybean 28% (DBPCFC, n=111) | Sampson & Ho 1997 |
USA, Denver, CO
a) 74 food allergic children (age of <3 years) b) 111 food allergic children (age of 3-19 years) |
a) soybean 16% (DBPCFC)
b) soybean 2.7% (DBPCFC) |
Bock & Atkins 1990 |
USA, Durham, NC
a) 113 food allergic children with atopic dermatitis b) 63 DBPCFC positiv children of a) |
a) soybean 30% (SPT)
b) soybean 8% (DBPCFC) |
Sampson & McCaskill 1985 |
USA, Little Rock, AR
165 patients with atopic dermatitis |
soybean 13% (SPT) from which 3/19 were DBPCFC-positive | Burks et al. 1998 |
USA, New Haven, CT
98 infants and children with multiple gastrointestinal allergies |
soy and milk 62%
soy and gluten 35% (clinical histroy) |
Gryboski & Kocoshis 1980 |
USA, OH
148 respiratory-allergic children with reproduced symptoms after food challenge |
soy formula 5% (oral challenge) | Ogle et al. 1980 |
USA, San Diego, CA
cow's milk-sensitive infants |
soybean 25% | Wilson & Hamburger 1988 |
USA, San Diego, CA
93 cow's milk-allergic children (<3.5 years) |
soybean 14 % (DBPCFC, open challenge, or convincing history of an anaphylactic reaction) | Zeiger et al. 1999 |
2 Outgrowing / Persistence of Soybean
Allergy
Country / Subjects | Sensitivity to | References |
Spain, Barcelona
patients with asthma (associated to asthma outbreak during the unloading of soybeans, 1981-1987) |
Soybean in 55% of patients with epidemic asthma and 6.0% of those with non-epidemic asthma (p<0.05) 8 years after outbreak (RAST, measurable levels in 1995 and 1989 almost identical) | Anto et al. 1999 |
USA
Food allergic patients |
soy, egg, milk, wheat, and peanut:
26% loss (after 1 year of onset, DBPCFC) |
Sampson & Scanlon 1989 |
USA
infants (mean age 8 weeks) with food protein-induced enterocolitis syndrome caused by soybean |
soy in 2 of 8 (after 25 months) | Sicherer et al. 1998 |
Symptoms & Case Reports | References |
systemic reactions
anaphylaxis (5, 7, 13, 15, 22), exercise-induced anaphylaxis (25), fatal reactions (12, 22) cutaneous symptoms
gastrointestinal symptoms
respiratory symptoms
other symptoms
|
(1) Virchow 1965
(2) Fries 1971 (3) Bush & Cohen 1977 (4) Whitington & Gibson 1977 (5) Moroz & Yang 1980 (6) Bush et al. 1985 (7) Stricker et al. 1986 (8) Richards et al. 1988 (9) Bush et al. 1988 (10) Burks et al. 1991 (11) Gonzalez et al. 1991 (12) Yunginger et al. 1991 (13) Patane et al. 1992 (14) Herian et al. 1990 (15) Andersen & Nissen 1993 (16) Burks et al. 1994 (17) Lavaud et al. 1994 (18) Machida et al. 1994 (19) Räsänen et al. 1994 (20) Magnolfi et al. 1996 (21) Sicherer et al. 1998 (22) Foucard & Malmheden Yman 1999 (23) Niggemann et al. 1999 (24) Ikeda et al. 2000 (25) Steurich & Feyerabend 2000 |
Percentage of Reactions
cutaneous 68%, gastrointestinal 77%, respiratory 23% in 31 soybean-allergic patients with atopic dermatitis (1) cutaneous 58%, gastrointestinal 14%, both 28%, respiratory 0%, early reaction 57%, late reactions 43% in 7 soybean-allergic patients (2) |
(1) Sampson & Ho 1997
(2) Niggemann et al. 1999 |
Threshold for Elicitation of Symptoms
Amounts of soybeans inducing allergic symptoms ranged from 1 g to 8 g (estimated protein content: 0.3 - 2.7 g) (DBPCFC, 4 soybean allergic children) (1) Estimated amount of soy intake in 4 fatal cases: 1-10 g as hidden allergen (2) Amounts of soybean inducing symptoms: </= 500 mg in 28% (DBPCFC, 196 food allergic children with atopic dermatitis) (3) |
(1) Bock et al. 1978
(2) Foucard & Malmheden Yman 1999 (3) Sicherer et al. 2000 |
4 Diagnostic Features of Soybean Allergy
Parameters / Subjects | Outcome | References |
IgA and IgM
5 patients with soy allergy (previously suffering from cow's milk allergy) |
increased numbers of IgA- and IgM- containing cells (jejunal biopsy) | Perkkio et al. 1981 |
IgE and IgD
13 children with various intestinal diseases |
increased levels of IgE and IgD antibodies specific for soybean agglutinin (and milk proteins) in basal and pancreozymin- stimulated duodenal fluid | Freier et al. 1983 |
T-Cells
7 cases of fatal soybean dust-induced asthma |
reduced numbers of CD3+ and CD8+ T-cells in airways | Synek et al. 1996 |
Ig-Classes
a) 12 soydust-asthmatic patients b) 23 asthmatic patients c) 32 non-allergic subjects |
positive results in patients (specific Ig):
a) IgE 100%, IgG 75%, IgG1 16.6%, IgG2 8.3%, IgG3 0%, IgG4 66.6%, IgA 25%, and IgM 25% b) IgE 4.3%, others negative c) IgE 0%, IgG 0%, IgG1 6.2%, IgG2 9.4%, IgG3 9.4%, IgG4 9.4%, IgA 6.2%, and IgM 6.2% significant positive correlation: for IgE and IgG4 in a) only |
Codina et al. 1997a |
a) RAST and DBPCFC
b) SPT and DBPCFC food-allergic children with atopic dermatitis |
a) predictive values of specific IgE > 0.35 kU/L
positive predictive value 21% (50% for IgE > 65 kU/L) negative predictive value 95% b) predictive values of SPT ( > 3 mm) positive predictive value 35% negative predictive value 84% |
Sampson & Ho 1997 |
SPT and DBPCFC
Children suspected of IgE-mediated symptoms to soybean |
No significant differences in wheal sizes between individuals who were allergic or tolerant to soybean | Eigenmann & Sampson 1998 |
IgE and DBPCFC
children with atopic dermatitis |
a) Specific serum IgE in children with
positive oral provocation: 7.4 kU/L negative oral provocation: 3.2 kU/L (no significant difference) b) predictive value of specific IgE > 0.35 kU/L positive predictive value 23% negative predictive value 100% |
Niggemann et al. 1999 |
Proteins / Glycoproteins | Allergen Nomenclature | References |
Soybean Hydrophobic Protein [7.5 / 7 kDa] | Gly m 1.0101, Gly m 1.0102 | Gonzalez et al. 1995 |
Soybean Hull Protein [8 kDa] | Gly m 2 | Codina et al. 1997b |
Soybean Profilin [14 kDa] | Gly m 3 | Rihs et al. 1999 |
Soybean Vacuolar Protein (Gly m Bd 30K) [30 kDa] | (formerly Gly m 1)* | Ogawa et al. 1991 |
Glycinin [subunits 58-62 kDa] | Djurtoft et al. 1991 | |
alpha subunit of
beta-Conglycinin [subunits 42-76 kDa] |
Ogawa et al. 1995 | |
Kunitz-trypsin Inhibitor [20 kDa] | Moroz & Yang 1980 ,
Burks
et al. 1994b ,
Baur et al. 1996 |
6.1 Sensitization to Soybean Allergens
Country / Subjects | Sensitivity to | References |
Australia, North Ryde
8 peanut sensitive patients |
soybean lectin: agglutinin (30 kDa) in all patients (RAST) | Barnett & Howden 1987 |
Denmark
10 soybean sensitive patients |
Glycinin in 90%
glycinin subunits in 100% (EAST) |
Djurtoft et al. 1991 |
Germany, Bochum
14 soybean-sensitized asthmatic bakers |
trypsin inhibitor in 86%
lipoxidase in 43% lectin in 21% (RAST) 14 kDa / pI 8 allergen in 14% (2D-immunoblot) |
Baur et al. 1996 |
Germany, Bochum
13 soybean-sensitized patients |
profilin (Gly m 3) in 69% (immunoblot, EAST) | Rihs et al. 1999 |
Germany, Langen
6 soybean-allergic adults |
10 proteins, major allergens: 39 and 50 kDa (SDS-PAGE / immunoblot) | Müller et al. 1998 |
Japan, Gunma
5 soybean sensitive children |
2S > 7S > 11S fraction (RAST, allergenic potency: RAST inhibition) | Shibasaki et al. 1980 |
Japan, Nagano
30 soybean- sensitive patients (including 7 challenge positive patients) |
whey fraction:
20 kDa and 58 kDa allergens globulin fraction: 26 kDa and 31 kDa allergens Monosensitization to 78 kDa allergen of globulin fraction in 2 challenge positive patients (SDS-PAGE immunoblot) |
Awazuhara et al. 1997 |
Japan, Tokushima
soybean-sensitized patients with atopic dermatitis |
16 allergens, (14-97 kDa):
7S fraction: 10 allergens, Gly m Bd 30K in 65% alpha- subunit (beta- conglycinin) in 23%; 2S and whey fraction: 6 allergens (SDS-PAGE immunoblot) |
Ogawa et al. 1991
Ogawa et al. 1995 |
Japan, Tokushima
soybean-sensitized patients with atopic dermatitis |
26 kDa allergen (Gly m Bd 28K) in 23%
(SDS-PAGE immunoblot) |
Ogawa et al. 1991
Tsuji et al. 1997 |
Spain, Barcelona
10 patients with asthma |
soybean hull and dust extracts: minor allergens (21 to 42 kDa), major allergen < 14 kDa glycopeptide, pI < 6 (SDS- and IEF-PAGE immunoblot ) | Rodrigo et al. 1990
Swanson et al. 1991 |
Spain, Barcelona
15 soybean-sensitized patients with asthma |
2 nonoverlapping IgE binding patterns:
a) in 73% 3 allergens : 8, 7.5 and 7 kDa (Gly m 2, Gly m 1.0101 and Gly m 1.0102) b) in 20% 1 allergen at 8.2-8.3 kDa and 4 allergens at 25-36 kDa (SDS-PAGE immunoblot) |
Codina et al. 1999 |
Spain, Cartagena
32 patients with asthma |
shell allergens of soy dust in 90%; major allergen of 8 kDa (RAST, immunoblot) | Gonzalez et al. 1991 |
Spain, Cartagena
20 patients with asthma sensitized to soy |
Gly m 1.0101 / Gly m 1.0102 in 95%
(EAST) |
Gonzalez et al. 1992 |
Spain, Tarragona
13 patients with asthma sensitized to soy |
5-6 kDa allergen in 62%
15.5-17 kDa allergen in 77% (SDS-PAGE / immunoblot) |
Garcia-Ortega et al. 1998 |
UK, London
21 patients with wheat-induced asthma |
21 kDa allergen in 100%
15 kDa allergen in 19% (SDS-PAGE / immunoblot) |
Sandiford et al. 1995 |
USA, Little Rock, AR
8 Children with atopic dermatitis and soy allergy |
7S and 11S protein fractions: increased specific serum IgE and IgG (ELISA) | Burks et al. 1988 |
USA, Little Rock, AR
8 Children with atopic dermatitis and soy allergy |
crude soy extract and 7S fraction: increased specific
IgE;
whey and 11S: no significant difference in IgE-binding (EAST) 7S and 11S fraction detected by all sera (SDS-PAGE / immunoblot) |
Burks et al. 1991 |
USA, Little Rock, AR
5 patients with atopic dermatitis and soy allergy |
trypsin inhibitor in 1 patient (spec. IgE, immunoblot, EAST) | Burks et al. 1994b |
USA, Little Rock, AR
2 soybean-allergic patients, 1 soybean- and peanut- allergic patient |
17, 21, 26, and 45 kDa allergens (SDS-PAGE / immunoblot) | Eigenmann et al. 1996 |
USA, Little Rock, AR
4 patients with atopic dermatitis and soy allergy |
20, 30-35, 50, and 65 kDa allergens (SDS-PAGE / immunoblot) | Helm et al. 1998 |
USA, Madison, WI
1 soybean-asthmatic patient |
14.8, 17, 21, 48, 52, and 54.5 kDa allergens (SDS-PAGE / immunoblot) | Bush et al. 1988 |
USA, Madison, WI
7 soybean allergic adults |
50-60 kDa allergens in 57% (patients with soy and peanut
allergy)
20 kDa allergen in 29% (detected by monosensitized patients) 14 kDa allergen in 14% (SDS-PAGE / immunoblot) |
Herian et al. 1990 |
6.2 Soybean Hydrophobic Protein (Gly m 1)
6.3 Soybean Hull Protein (Gly m 2)
6.4 Soybean Profilin (Gly m 3)
6.5 Soybean Vacuolar Protein (Gly m Bd 30K)
6.6 Glycinin
6.7 beta-Conglycinin
6.8 Kunitz-trypsin Inhibitor
Extract / Purified Allergens | Methods | References |
Hydrophobic protein (Gly m 1.0101) | 60% ethanolic extract of seeds | Odani et al. 1987 |
Commercial and self-prepared extracts | abscence of high Mr proteins in commercial extracts (SDS-PAGE immunoblot) | Herian et al. 1992 |
Gly m 1.0101, Gly m 1.0102 | Purification by SEC / RP-HPLC | Gonzalez et al. 1992 |
Soybean trypsin inhibitor | Extraction from soy protein isolate with PBS for 4h at 4°C; Purification by gel filtration and electroelution | Burks et al. 1994b |
Gly mBd 28K | Isolation from defatted soybean flakes using 5 chromatographic steps including immunoaffinity chromatography with a mAb | Tsuji et al. 1997 |
Soybean proteins | Soybeans frozen, ground (<-5°C) and extracted
with PBS for 4h at 4°C
Soybean lecithin extracted in a two phase aqueous / organic solvent system, purification of aqueous phase by gel chromatography |
Müller et al. 1998 |
Soybean hull | grounded hulls: extraction with ammonium bicarbonate buffer (0.2 M, pH 7.9) overnight, centrifugation, dialysis and centrifugation | Morell et al. 1999 |
Cross-Reacting Allergens | Subjects / Methods | References |
Soybean
soybean (sensitivity in 90% of patients), peanut (90%), green pea (80%), lima bean (53%), string bean (43%)* |
30 atopic children with suspected soybean allergy (Skin test) | Fries 1971 |
Soybean
peanut, garden pea, and chick pea |
15 peanut-sensitive patients (RAST-inhibition) | Barnett et al. 1987 |
Soybean allergen (17
kDa)
green pea (17 kDa) |
1 patient with asthma (immunoblotting) | Bush et al. 1988 |
Soybean
soybean (sensitivity in 43% of patients), peanut (87%), green bean (22%), pea (26%), and lima bean (41%)* |
69 legume-sensitive patients (SPT) (1)
frequency of multiple sensitization: 4.9% (DBPCFC, 41 patients) (1) in vitro cross-reactivity did not correlate with clinical hypersensitivity (SDS-PAGE and dot / immunoblot) (2) |
(1) Bernhisel-Broadbent
& Sampson 1989
(2) Bernhisel-Broadbent et al. 1989 |
Soybean
peanut |
patient allergic to peanut and soy:
73% reduction of IgE-binding to peanut after adsorption of cross-reacting antibodies (ELISA) |
Eigenmann et al. 1996 |
Soybean
wheat, rye, and barley flours |
21 patients with wheat-induced asthma
(RAST inhibition) |
Sandiford et al. 1995 |
Soybean
wheat flour (sensitivity in 80% of patients), rye flour 66%, alpha-amylase of Aspergillus oryzae (Asp o 2) 33%* |
14 soybean-sensitized asthmatic bakers
(RAST) |
Baur et al. 1996 |
Soybean
peanuts and peas |
4 peanut allergic and 2 pea allergic adults (RAST-inhibition) | Hagner et al. 1998 |
Soybean
corn, rice, and peanut |
soybean, corn, rice, and peanut allergic patients: significant inhibition of IgE- binding to soybean by corn, rice, and peanut (RAST inhibition) | Lehrer et al. 1999 |
Soybean Profilin Gly m 3
birch pollen profilin Bet v 2 |
Complete inhibition of IgE-binding to Bet v 2 by recombinant Gly m 3 (EAST inhibition, 2 soybean sensitive patients) | Rihs et al. 1999 |
Unique Allergens | Subjects / Methods | References |
Soybean / Peanut
46 and 21 kDa allergens from soybean did not cross-react with peanut allergens; 46, 29, 25, 19, 17, 14, and 5 kDa allergens from peanut did not cross-react with soybean allergens |
2 patients allergic to peanut and soy
3 patients allergic to peanut a) removal of cross-reacting antibodies from serum by soy- and peanut-affinity chromatography, respectively b) detection of unique IgE-binding proteins in SDS-PAGE immunoblot |
Eigenmann et al. 1996 |
9 Stability of Soybean Allergens
Treatment | Effects | References |
Soybean hull (Storage)
(a) fresh, (b) stored, (c) stored and heated for 16 h |
IgE- and IgG4-binding:
stored > fresh extracts heated > untreated extracts (EAST inhibition) heated to 80°C: absence of several bands > 20 kDa abscence of 1 major allergen (probably Gly m 2) 2 new IgE-binding bands of 10 and 15.3 kDa 1 new IgG4-binding band of 10 kDa as compared to RT, 37°C, 55°C treatment (SDS-PAGE immunoblot) |
Codina et al. 1998 |
Soybean hull (Storage)
fresh and glycerinated extracts: storage (30 days, -70°C to 4°C) |
increase of positivities in SPT with all glycerinated
extracts after 30 days of storage,
loss of protein bands > 66 kDa for non-glycerinated extract stored at 4°C (SDS-PAGE) |
Morell et al. 1999 |
Soybeans (Heat)
microwave 700W, 25 min 15 soybean-allergic adults |
IgE-binding (EAST):
raw soybean: 15 sera heated soybean: 9 sera |
Vieths et al. 1995 |
Soybeans (Heat)
cooking 100°C, 2h 6 soybean-allergic adults |
IgE-binding (EAST):
raw soybean: 6 sera cooked soybean: 3 sera max. inhibition of Ig-binding to heated soybean extract (EAST): 39% by raw extract 89% by heated extract |
Müller et al. 1998 |
Crude Soy Protein (Heat)
heat 80°C and 120°C, 60 min |
decrease in IgE-binding
80°C: no change in IgG-binding 120°C: decrease in IgG-binding (ELISA) |
Burks et al. 1991 |
Crude Soy, 7S-, 11S-, and Whey Proteins
(Heat)
heat RT to 100°C, 5 to 60 min |
no significant changes in IgE- and IgG-binding (2 patients with soybean allergy, EAST inhibition) | Burks et al. 1992 |
Soy Whey Proteins (Heat)
heat 80°C and 120°C, 60 min |
80°C: no change in IgE- and IgG-binding
120°C: decrease in IgE- and IgG-binding (ELISA) |
Burks et al. 1991 |
11S-, 7S- and 2S-Globulins
(Heat)
heat 80°C, 100°C and 120°C, 30 min |
80°C: 2S-globuline slightly increased,
11S and 7S reduced IgE-binding (42-75%) 100°C, 120°: decreased IgE-binding for all fractions (39-83%) (RAST) |
Shibasaki et al. 1980 |
11S- and 7S-Globulins (Heat)
heat 80°C and 120°C, 60 min |
80°C: decrease in IgE-binding; decrease (7S) and
increase (11S) in IgG-binding
120°C: decrease in IgE- and IgG-binding (ELISA) |
Burks et al. 1991 |
Crude Soy Protein (Hydrolysis)
2 step enzyme digestion a) pepsin and b) trypsin, chymotrypsin and intestinal mucosal peptidase digestion |
50%-inhibition concentration: 10 fold increased for digested soy proteins (2 patients with soybean allergy, EAST inhibition) | Burks et al. 1992 |
Crude Soy Protein (Hydrolysis)
enzyme digestion (2 proteases) |
reduced IgE-binding (immunoblot) | Yamanishi et al. 1996 |
Glycinin, beta-Conglycinin
(Hydrolysis)
a) in vitro digestion with trypsin b) in vivo digestion of a processed soy ingredient in rats |
a) beta-Conglycinin: decrease in
immunoreactivity; Glycinin: 3-fold increase in immunoreactivity (ELISA,
rabbit antibody)
b) Glycinin and beta-conglycinin were digested rapidly, intact globulins disappeared from the gastrointestinal tract within 3 h; immunoreactive globulins in gut contents and associated with gut tissues in a semi-intact form, probably comprising proteolytic intermediates |
Perez et al. 2000 |
Reported Adverse Reactions | References |
Several Food Products
Fatal anaphylaxis of a 10 year old girl sensitized to peanut and soy (RAST) after ingestion of sausage pizza fortified with soy protein (1) Symptoms after ingestion of tofu, soybean salat, soybean sprouts, and spring rolls (2) Baker's asthma induced by soy lecithin (Skin test, RAST, bronchial challenge) (3) Soy proteins in Spanish sausage products (chorizo, salchichon, mortadella, and boiled ham), doughnut and soup stock cubes (Skin test, RAST, bronchial and oral challenge) (4) Anaphylactic symptoms caused by pizza containing soy proteins (5) 4 fatal anaphylactic reaction in adolescents with known peanut allergy and unrecognized soybean allergy caused by meatballs with 3% soyprotein, hamburger (1 case soyprotein content unkown, other case 2.2% soyprotein), and kebab with 7% soyprotein (6) 6 life-threatening allergic reactions after ingestion of ice cream and meatballs with soy, and soysauce (6) |
(1) Yunginger et al. 1991
(2) Mistereck et al. 1992 (3) Lavaud et al. 1994 (4) Vidal et al. 1997 (5) Senne et al. 1998 (6) Foucard & Malmheden Yman 1999 |
Hamburger, Kebab, Crab Stick
Fatal anaphylactic reaction after ingestion of a hamburger with added soyprotein (2.1%); 2 additional allergic reaction after ingestion of a kebab containing 7% soyprotein and a crab stick with 0.5-0.9% undeclared soyprotein |
Malmheden Yman et al. 1994 |
Tofu
Urticarial contact dermatitis in a 20 year old woman after contact with tofu (SPT, Immunoblot) |
Ikeda et al. 2000 |
Soy lecithins
Positive DBPCFC with 100 mg soy lecithins in a 4 year old boy , symptoms of erythematous rash on the jaws 1 h after ingestion |
Palm et al. 1999 |
Pharmaceuticals
Urticarial eruptions associated with lipid emulsions (1) Anaphylactic shock after infusion of soybean oil based preparation for parenteral nutrition (2) Systemic reactions (flush, dyspnea, tachycardia, hypotension, back pain) to a parenteral lipid emulsion, reexposure to parenteral solutions containing no soy lecithin emulsifier was tolerated (3) |
(1) Buchman & Ament 1991
(2) Andersen & Nissen 1993 (3) Weidmann et al. 1997 |
Allergens in Soybean Products | Content / Products | References |
Soybean Proteins
7 soybean-allergic adults (RAST inhibition) |
Inhibitory potency of IgE-binding to raw soybean proteins
(max. Inhibition):
raw soybeans (70%), sprouts (70%) > acid- hydrolyzed sauce (40%), tofu (25-30%), hydrolyzed vegetable protein (40%), tempeh (20%), miso (20%) > mold-hydrolyzed sauce (10%) |
Herian et al. 1993 |
Soybean Proteins
15 soybean-allergic adults (EAST inhibition) |
IgE-binding proteins in
soy-milk, tofu, textured soy-protein |
Vieths et al. 1995 |
Soybean Proteins
Patients with atopic dermatitis and high levels of IgE; Determination of IgG-binding to protein fractions (ELISA, immunoblot) |
IgG-binding proteins in
commercial margarines not detected in hypoallergenic magarine |
Yokota et al. 1996 |
Soybean Proteins
30 soybean-allergic adults (immunoblot) |
IgE-binding proteins in
lecithins (31 kDa allergen) protein contents: soybean lecithin 2.8 mg / 100 g soybean oil 1.4 to 4.0 µg / 100 g |
Awazuhara et al. 1998 |
Soybean Proteins
6 soybean-allergic adults (EAST, immunoblot) |
IgE-binding proteins in
4/6 commercial lecithins: 27, 39, and 40 kDa allergens |
Müller et al. 1998 |
Gly m Bd 30K
Determination of Gly m Bd 30K (ELISA) |
high concentrations in
soy milk, tofu, kori-dofu, yuba, and in soybean protein isolate containing foods meat balls, beef croquettes, and fried chicken low concentration in kinako not detected in fermented foods (miso, shoyu, and natto) |
(1) Tsuji et al. 1995 |
Gly m Bd 28K
Determination of Gly m Bd 28K (ELISA) |
detected in : soy milk, tofu, kori-tofu, yuba
not detected in: fermented foods (miso, shoyu, and natto), meat ball, beef croquettes, and fried chicken (1) |
(1) Bando et al. 1998 |
Reported Safe Products | References |
Soybean Oil
6 commercial soybean oil samples: safe ingestion of total dose of 15 mL by 7 soybean allergic individuals (DBPCFC) (1) |
(1) Bush et al. 1985 |
Pharmaceuticals
tolerance to parenteral solutions containing no soy lecithin emulsifier (1) |
(1) Weidmann et al. 1997 |
Allergen Depleted Products | Method | References |
Soy Protein Isolate
90% removal of allergen Gly m Bd 30K (1) |
salted out with Na2SO4, acidifying to pH 4.5 and centrifugation (1) | (1) Samoto et al. 1994 |
Soy Protein Isolate
from a genetically mutated soybean (Tohoku 124): 99.78% removal of allergen Gly m Bd 30K (1) |
salted out with Na2SO4, acidifying to pH 4.5 and centrifugation (1) | (1) Samoto et al. 1996b |
Soybean Mutants
lacking alpha and alpha' subunits of beta- conglycinin (1) lacking the 7S globulin (beta-conglycinin) subunits, alpha, alpha' and beta (2) |
soybean mutation induced by gamma- ray irradiation (1)
soybean variety produced by classical breeding techniques (2) |
(1) Takahashi et al. 1996
(2) Hayashi et al. 1998 |
11 Soybean Protein in Infant Feed
Subjects | Feeding / Formula | References |
328 children with a positive family history of allergy (15 years follow up) | Breast fed infants were found to have approximately one-half the incidence of atopy of cow's milk or soy based formula fed infants | Gruskay 1982 |
16 infants with congenital lactase deficiency (lactose malabsorption) | 10 on soy-based formula
1 had allergic symptoms |
Savilahti et al. 1983 |
101 newborn infants of atopic parents
(total serum IgE) |
development of atopic disease
breast-fed group: 38% with IgE > 0.8 U/ml 12% with IgE < 0.8 U/ml soy-fed group: 33% with IgE > 0.8 U/ml 16% with IgE < 0.8 U/ml cow's milk-fed group: 90% with IgE > 0.8 U/ml 17% with IgE < 0.8 U/ml |
Businco et al. 1983 |
97 brest fed and 124 non brest fed infants | development of atopic eczema
breast-fed group: 22% (restricted maternal diet) 48% (no restricted maternal diet) soy-fed group: in 63% cow's milk-fed group: in 70% casein hydrolysate-fed group: in 21% |
Chandra et al. 1989a |
72 infants with family history of atopy (each group) | incidence of atopic eczema, wheezing, rhinitis, gastrointestinal
symptoms, or colic
breast-fed group: in 20% soy-fed group: in 37% cow's milk-fed group: in 36% cow's milk whey hydrolysate-fed group: in 7% cumulative incidence of atopic disease: breast-fed and whey hydrolysate-fed group < cow's milk and soy-formula fed group |
Chandra et al. 1989b
Chandra & Hamed 1991 Chandra 1997 |
20 cow's milk allergic infants | incidence of allergic symptoms:
2S protein fraction depleted soy milk in 17% of infants |
Marano et al. 1989 |
(a) 12 infants with protracted enteritis
(b) 10 infants with atopic eczema |
fed with lactose-free soy and beef hydrolysate based
formula:
improvement of symptoms in both groups, allergic symptoms in 1 (a) and 3 (b) infants who were previously fed with intact soy protein |
Donzelli et al. 1990 |
21 infants with gastrointestinal symptoms of cow's milk and/or soy protein intolerance | fed with whey protein hydrolysate formula: improvement of symptoms | Merrit et al. 1990 |
40 atopic children | specific IgE against soy / beef collagen hydrolysate in 1 patient | Gortler & Urbanek 1990 |
43 patients with possible milk- and/or soy-protein enterocolitis | cow's milk
23% positive challenge 2 hydrolyzed soy protein isolates a) 33% positive challenge b) 30% positive challenge |
Burks et al. 1994 |
12 infants with adverse reactions to soy formula, whey hydrolysate, or casein hydrolysate (4) | infant formula composed of individual amino acids: no symptoms | Hill et al. 1995 |
analysis of 17 studies | allergy to soy-based formula:
in 27% of patients (total incidences), 3% (DBPCFC) and 4% (positive challenge) |
Cantani & Lucenti 1997 |
12 Allergenicity of Genetically Modified
Soybeans
Product | References |
Transgenic Soybean / Pesticide resistant
Aim: glyphosate-tolerant soybeans (product Roundup Ready) Modification: Introduced enzyme: 5-enolpyruvylshikimate- 3-phosphate synthase enzyme derived from Agrobacterium sp. strain Digestability: introduced enzyme degrades readily in simulated gastric and intestinal fluids (2) Allergenicity: no discernible changes, either qualitatively or quantitatively, in composition of endogenous soybean allergens in either of the glyphosate- tolerant varieties analyzed (1) |
(1) Burks & Fuchs 1995 (2) Harrison et al. 1996 |
Transgenic Soybean / Brazil nut protein
Aim: Improvement of nutritional quality Modification: Introduced allergen: methionine-rich 2S albumin from the Brazil nut (Betholletia excelsa) Allergenicity: All patients with positive reactions to brazil nut proteins were positive to the transgenic soybean (SPT, RAST, immunoblot) (Product withheld from the market by the company) |
Nordlee et al. 1996 |
Transgenic Soybean / Corn proteins
Aim: Improvement of nutritional quality (amino acid composition) Modification: Introduced corn proteins: 10 kDa and HSZ Allergenicity: Both proteins did not bind IgE from sera of corn-reactive subjects (immunoblot) |
Lehrer & Reese 1997 |
Transgenic Soybean / Oleic acid
Modification: transgenic soybean with an altered fatty acid profile Allergenicity: no difference in allergen content of wild-type and transgenic soybean extracts (RAST inhibition, immunoblot) |
Lehrer & Reese 1997 |
Cultivar Tohoku 124
lacks alpha- and alpha'-subunits of conglycinin which bind allergen Gly m Bd 30K (1) and lacks Gly m Bd 28K (2) |
(1) Samoto et al. 1996b
(2) Samoto et al. 1997 |
Food Allergen | Labelling / Regulation Status | References |
International Regulations
Peanuts, soybeans and products of these |
mandatory labelling of prepackaged food / advisary status (1) | (1) Codex Alimentarius Commission 1999 |
European Regulations
Soybean and Soybean Products |
labelling appropriate / recommendation (1) | (1) Bousquet et al. 1998 |